Surfactant replacement therapy

Kresch, M J; Lin, W H; Thrall, R S
November 1996
Thorax;Nov1996, Vol. 51 Issue 11, p1137
Academic Journal
No abstract available.


Related Articles

  • Is Surfactant a Promising Additive Drug in ALI / ARDS-Patients? Schultz, Marcus J.; Kesecioglu, Jozef // Current Drug Targets;Jul2004, Vol. 5 Issue 5, p445 

    The rationale for surfactant replacement therapy in patients with acute respiratory distress syndrome (ARDS) is to restore the normal composition of the surfactant system, as well as to overcome ongoing inactivation of present surfactant. Indeed, surfactant replacement therapy can normalize the...

  • Therapy for bronchopulmonary dysplasia in premature infants focuses on reducing the effects of oxygen toxicity and mechanical ventilation. Adis International Limited // Drugs & Therapy Perspectives;Jul2005, Vol. 21 Issue 7, p11 

    Discusses the management of bronchopulmonary dysplasia (BPD) in premature infants. Benefits of surfactant replacement therapy in intubated infants; Side effects of systemic glucocorticoids; Usefulness of oxygen therapy.

  • Surfactant Replacement Therapy in the Neonate: Beyond Respiratory Distress Syndrome. Donn, Steven M.; Dalton, Jennifer // Respiratory Care;Sep2009, Vol. 54 Issue 9, p1203 

    Surfactant-replacement therapy is a life-saving treatment for preterm infants with respiratory distress syndrome, a disorder characterized by surfactant deficiency. Repletion with exogenous surfactant decreases mortality and thoracic air leaks and is a standard practice in the developed world....

  • DISCOVERY LABS INITIATES PHASE 1B ASTHMA CLINICAL TRIAL.  // Biotech Business;Feb2004, Vol. 17 Issue 2, p3 

    Reports on the Phase 1b clinical trial initiated by Discovery Laboratories Inc. for the safety evaluation of a humanized lung surfactant to treat asthma, a part of its Surfactant Replacement Therapies for the treatment of respiratory diseases.

  • Surfactant-Associated Proteins: Structure, Function and Clinical Implications. Ketko, Anastasia K.; Donn, Steven M. // Current Pediatric Reviews;May2014, Vol. 10 Issue 2, p162 

    Surfactant replacement therapy is now the standard of care for infants with respiratory distress syndrome. As the understanding of surfactant structure and function has evolved, surfactant-associated proteins are now understood to be essential components of pulmonary surfactant. Their structural...

  • Neonatology in the 1990's: Surfactant Replacement Therapy Becomes a Reality. Berry, David D. // Clinical Pediatrics;Mar1991, Vol. 30 Issue 3, p165 

    It has been more than 35 years since the lung was discovered to be lined with a layer of surface-active material that is important in lung stability and mechanics of respiration. The absence of this "anti-atelectasis" factor was proposed by Avery and Mead in 1959 to be the cause of hyaline...

  • Pulmonary Hemorrhage (PH) in Extremely Low Birth Weight (ELBW) Infants: Successful Treatment with Surfactant. SURYAWANSHI, PRADEEP; NAGPAL, REMA; MESHRAM, VAIBHAV; MALSHE, NANDINI; KALRAO, VIJAY // Journal of Clinical & Diagnostic Research;Mar2015, Vol. 9 Issue 3, p3 

    We report a case of an extremely low birth weight (ELBW) infant presenting with pulmonary hemorrhage (PH) in which we have given surfactant after an acute episode of bleeding with severe intractable hypoxemia. Surfactant replacement therapy showed improvement in Mean Airway Pressure (MAP) and...

  • Pulmonary surfactant: functions, abnormalities and therapeutic options. Frerking, Ilka; G√ľnther, Andreas; Seeger, Werner; Pison, Ulrich // Intensive Care Medicine;Nov2001, Vol. 27 Issue 11, p1699 

    The first successful clinical pilot studies of surfactant replacement were published about 20 years ago as a logical extension of experimental studies showing beneficial effects in pre-term animals. The efficacy of this therapy for immature new-borns has been confirmed in various controlled...

  • Pulmonary surfactant: a front line of lung host defense. Wright, Joe Rae // Journal of Clinical Investigation;5/15/2003, Vol. 111 Issue 10, p1453 

    Investigates the functions of lung innate immune system, pulmonary surfactant. Description of pulmonary surfactant; Antibacterial functions of the surfactant; Surfactant therapy for infectious and inflammatory lung diseases.

  • AARC Clinical Practice Guideline. Surfactant Replacement Therapy: 2013. Walsh, Brian K.; Daigle, Brandon; Diblasi, Robert M.; Restrepo, Ruben D. // Respiratory Care;Feb2013, Vol. 58 Issue 2, p367 

    We searched the MEDLINE, CINAHL, and Cochrane Library databases for English-language randomized controlled trials, systematic reviews, and articles investigating surfactant replacement therapy published between January 1990 and July 2012. By inspection of titles, references having no relevance...


Read the Article


Sign out of this library

Other Topics